NCR2 and acute myeloid leukemia: NK cells isolated from AML patients have decreased expression of NCRs NKp46, NKp30, NKp44, NKp80, and 2B4, increased expression of inhibitory CD94/NKG2A, shedding of activating ligands (e.g., CD16) and decreased killing activity (58).